Watershed Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$380K Buy
2,665
+156
+6% +$23.7K 0.1% 91
2026
Q2
$393K Hold
2,509
– – 0.11% 94
2026
Q1
$383K Sell
2,509
-156
-6% -$23.9K 0.12% 87
2025
Q4
$367K Hold
2,665
– – 0.11% 91
2025
Q3
$342K Hold
2,665
– – 0.11% 88
2025
Q2
$322K Sell
2,665
-265
-9% -$29.9K 0.12% 84
2025
Q1
$327K Buy
+2,930
New +$312K 0.13% 89
2024
Q4
– Sell
-1,989
Closed -$229K – 117
2024
Q3
$229K Hold
1,989
– – 0.09% 103
2024
Q2
$212K Sell
1,989
-187
-9% -$18.8K 0.09% 108
2024
Q1
$210K Sell
2,176
-235
-10% -$24.1K 0.09% 120
2023
Q4
$243K Buy
+2,411
New +$233K 0.13% 94

Other funds holding NVS

Watershed Private Wealth's NVS Position: Q3 2026 in Review

Watershed Private Wealth increased its Novartis (NVS) stake by 6.2% in Q3 2026, buying an estimated $23.7K and bringing the position to 2,665 shares worth $380K. The position accounts for 0.1% of the portfolio, ranked #91.

Watershed Private Wealth first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $393K in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Watershed Private Wealth held 2,665 shares of Novartis worth $380K as of Q3 2026.
  • Watershed Private Wealth bought 156 Novartis shares in Q3 2026, an estimated $23.7K.
  • Novartis made up 0.1% of Watershed Private Wealth's portfolio in Q3 2026, its #91 holding.
  • Watershed Private Wealth first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • Watershed Private Wealth's Novartis position peaked at $393K in Q2 2026.
  • 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Watershed Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.